title: Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
authors.affiliation: State Reference Center for Sanitary Dermatology and Leprosy, Clinical Hospital, Faculty of Medicine, Federal University of Uberlândia, Minas Gerai, Brazil. imbgoulart@ufu.br
authors.forename: Isabela M B
authors.initials: IM
authors.lastname: Goulart
authors.forename: Ana Cláudia S
authors.initials: AC
authors.lastname: Reis
authors.forename: Tatiana M N
authors.initials: TM
authors.lastname: De Rezende
authors.forename: Aércio S
authors.initials: AS
authors.lastname: Borges
authors.forename: Marcelo S
authors.initials: MS
authors.lastname: Ferreira
authors.forename: Sérgio A
authors.initials: SA
authors.lastname: Nishioka
mesh_terms: D000328:Adult; D000741:Anemia, Aplastic / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D001938:Brazil; D002991:Clofazimine / Q000009:adverse effects / Q000627:therapeutic use; D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015440:Leprosy, Lepromatous / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D007917:Leprostatic Agents; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin